SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-037056
Filing Date
2021-07-15
Accepted
2021-07-15 16:15:55
Documents
4
Period of Report
2021-07-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea144233-8k_oramedpharma.htm 8-K 29274
2 EQUITY DISTRIBUTION AGREEMENT, DATED JULY 15, 2021, BY AND BETWEEN THE COMPANY A ea144233ex1-1_oramedpharma.htm EX-1.1 236925
3 SECOND AMENDED AND RESTATED BY-LAWS, ADOPTED EFFECTIVE JULY 14, 2021 ea144233ex3-1_oramedpharma.htm EX-3.1 65450
4 SECOND AMENDED AND RESTATED BY-LAWS, ADOPTED EFFECTIVE JULY 14, 2021 ea144233ex3-2_oramedpharma.htm EX-3.2 50171
  Complete submission text file 0001213900-21-037056.txt   383283
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-35813 | Film No.: 211092858
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences